Phase II Anastrozole and ZD6474 in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer
This study has been terminated.
(Low accrual)
Sponsor:
Stanford University
Collaborator:
AstraZeneca
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT00481845
First received: May 31, 2007
Last updated: March 3, 2011
Last verified: March 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | December 2011 |
| Estimated Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |